Losartan improves diastolic ventricular filling of hypertensive patients with diastolic dysfunction.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Hypertension Research

• Publication date

  1999-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1291/HYPRES.22.155PMID 10487333
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors.

  1997cited by this paper
• Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)

  1997cited by this paper
• Effect of AT1 receptor blockade on cardiac collagen remodeling after myocardial infarction.

  1997cited by this paper
• Renin‐angiotensin system and myocardial collagen matrix: modulation of cardiac fibroblast function by angiotensin II type 1 receptor antagonism

  1997cited by this paper
• Altered ventricular and myocyte response to angiotensin II in pacing-induced heart failure.

  1996cited by this paper
• Effect of the renin-angiotensin-aldosterone system on the cardiac interstitium in heart failure.

  1996cited by this paper
• The renin-angiotensin-aldosterone system and myocardial collagen matrix remodelling in congestive heart failure.

  1995cited by this paper
• Angiotensin II receptor antagonists in heart failure: Rationale and design of the evaluation of losartan in the elderly (ELITE) trial

  1995cited by this paper
• Losartan in heart failure: preclinical experiences and initial clinical outcomes.

  1994cited by this paper
• Congestive heart failure from left ventricular diastolic dysfunction in systemic hypertension.

  1993cited by this paper
• The importance of the renin-angiotensin system in reversal of left ventricular hypertrophy.

  1993cited by this paper
• Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart.

  1993cited by this paper
• Pharmacology of nonpeptide angiotensin II receptor antagonists.

  1992cited by this paper
• Chronic captopril and losartan (DuP 753) administration in rats with high-output heart failure.

  1992cited by this paper
• Nonpeptide angiotensin II receptor antagonists. VII. Cellular and biochemical pharmacology of DuP 753, an orally active antihypertensive agent.

  1990cited by this paper
• The effects of antihypertensive therapy on left ventricular mass in elderly patients.

  1990cited by this paper
• Left ventricular hypertrophy and impaired diastolic filling in essential hypertension. Diastolic mechanisms for systolic dysfunction during exercise.

  1990cited by this paper
• Improved left ventricular filling accompanies reduced left ventricular mass during therapy of essential hypertension.

  1986cited by this paper
• Abnormal left ventricular filling: an early finding in mild to moderate systemic hypertension.

  1984cited by this paper
• Congestive heart failure with normal systolic function.

  1984cited by this paper
• Left ventricular diastolic function in hypertension: relation to left ventricular mass and systolic function.

  1984cited by this paper
• Measurement of Left Ventricular Wall Thickness and Mass by Echocardiography

  1972cited by this paper

• Diastolic heart failure: recognition, diagnosis and management

  2004cites this paper
• Paciente diabética con hipertensión acelerada que ingresa con clínica de insuficiencia cardíaca

  2004cites this paper
• [Diagnosis and therapeutic guidance of diastolic heart failure].

  2003cites this paper
• Treatment of chronic heart failure in a managed care setting. Baseline results from the Achieving Cardiac Excellence Project.

  2003cites this paper
• Candesartan cilexetil improves left ventricular function, left ventricular hypertrophy, and endothelial function in patients with hypertensive heart disease.

  2002cites this paper
• Effects of losartan on blood pressure and humoral factors in a patient who suffered from anaphylactoid reactions when treated with ACE inhibitors during LDL apheresis.

  2001cites this paper
• Effects of TCV-116 on endothelin-1 and PDGF A-chain expression in angiotensin II-induced hypertensive rats.

  2001cites this paper
• Variations in cardiac diastolic function in hypertensive patients with different left ventricular geometric patterns.

  2001cites this paper
• Acute effects of E-3174, a human active metabolite of losartan, on the cardiovascular system in tachycardia-induced canine heart failure.

  2001cites this paper
• Diastolic dysfunction and heart failure: causes and treatment options.

  2000cites this paper